rinzimetostat   Click here for help

GtoPdb Ligand ID: 14563

Synonyms: MRTX-2219 | ORIC-944 | ORIC944
PDB Ligand
Compound class: Synthetic organic
Comment: Rinzimetostat (ORIC-944, formerly MRTX-2219) is an orally bioavailable allosteric inhibitor that blocks histone binding at H3K27me3 by targeting the EED subunit of the polycomb repressive complex 2 (PRC2). This disrupts the repressive function of H3K27me3, and is proposed as a mechanism to promote tumour growth inhibition. EED inhibition is proposed as an alternative to inhibition of EZH2-mediated PRC2 function.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 1
Rotatable bonds 6
Topological polar surface area 76.25
Molecular weight 456.52
XLogP 1.71
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC1=C(C=CC(=C1)CN(C)C)C2=CN=C(NCC3=C4CCOC4=CC=C3F)N5C=C(C#N)N=C25
Isomeric SMILES CC1=C(C=CC(=C1)CN(C)C)C2=CN=C(N3C2=NC(=C3)C#N)NCC4=C(C=CC5=C4CCO5)F
InChI InChI=1S/C26H25FN6O/c1-16-10-17(14-32(2)3)4-5-19(16)22-13-30-26(33-15-18(11-28)31-25(22)33)29-12-21-20-8-9-34-24(20)7-6-23(21)27/h4-7,10,13,15H,8-9,12,14H2,1-3H3,(H,29,30)
InChI Key FLCIOLFIDGTRCI-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
embryonic ectoderm development Hs Allosteric modulator Negative >7.0 pIC50 - 1
⤷ pIC50 >7.0 (IC50 <1x10-7 M) [1]
Description: Measuring inhibition of histone H3 methylation mediated by the PRC2 complex in vitro